Press release content from Business Wire. The AP news staff was not involved in its creation.
Rallybio Reveals Details of Two Pipeline Programs with the Potential to Transform the Lives of Patients with Rare Diseases
March 2, 2021 GMT
NEW HAVEN, Conn. (BUSINESS WIRE) Mar 2, 2021
Rallybio, a clinical-stage biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders, today announced the details of two previously undisclosed pipeline programs. RLYB212 is a novel monoclonal antibody to human platelet antigen (HPA)-1a in preclinical development for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT), a potentially life-threatening rare disorder that can cause uncontrolled bleeding in fetuses and newborns. RLYB116 is a small protein inhibitor of complement factor 5 (C5) suitable for subcutaneous administration in preclinical development for the treatment of patients
Press release content from Business Wire. The AP news staff was not involved in its creation.
Tom De Weerdt Joins PCI Pharma Services as Senior Vice President, Chief Financial Officer, Former CFO Serge Dupuis Retiring
March 2, 2021 GMT
PHILADELPHIA (BUSINESS WIRE) Mar 2, 2021
PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider, today announced that Tom De Weerdt has joined the Company as Senior Vice President (SVP), Chief Financial Officer (CFO). Mr. De Weerdt succeeds Serge Dupuis, who is retiring.
ADVERTISEMENT
Tom De Weerdt joins PCI Pharma Services as Senior Vice President, Chief Financial Officer, replacing former CFO Serge Dupuis who is retiring (Photo: Business Wire)
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Highmark Health engages Verily to reinvent the healthcare experience for Highmark Health customers and clinicians
March 2, 2021 GMT
PITTSBURGH and SOUTH SAN FRANCISCO, Calif., March 2, 2021 /PRNewswire/ Highmark Health, a national blended health organization, today announced a strategic collaboration with Verily that will complement and build upon the partnership it recently announced with Google Cloud – sister company to Verily within Alphabet – to develop its Living Health model.
ADVERTISEMENT
The Living Health model is designed to eliminate the fragmentation in health care, re-engineering the health care delivery model to provide a seamless, simpler and smarter customer experience. In addition to offering improved interactions with patients, the Living Health model will free clinicians from time-consuming administrative tasks while providing them with timely personalized data, re
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Terracon Enhances Mid-Atlantic Presence with GET Solutions, Inc. Acquisition
March 2, 2021 GMT
Terracon logo (PRNewsfoto/Terracon)
OLATHE, Kan., March 2, 2021 /PRNewswire/ Terracon is pleased to announce it has acquired GET Solutions, Inc. (GET). As their name represents, GET is a full-service Geotechnical, Environmental, and materials Testing firm serving public- and private-sector clients throughout the mid-Atlantic region.
Headquartered in Virginia Beach, Virginia, GET also has office locations in Williamsburg, Virginia, and Elizabeth City and Jacksonville, North Carolina. GET’s services include in-house drilling capabilities and certified soils and concrete testing laboratories.
Press release content from Business Wire. The AP news staff was not involved in its creation.
TPG-Led Investor Group Announces Combination of Thycotic and Centrify to Create a Leading Cloud Identity Security Vendor
March 2, 2021 GMT
SAN FRANCISCO & WASHINGTON & SANTA CLARA, Calif. (BUSINESS WIRE) Mar 2, 2021
TPG Capital, the private equity platform of alternative asset firm TPG, announced today that it has signed a definitive agreement to combine Thycotic, a next-generation, cloud-first company with innovative identity security solutions, and Centrify, a trusted PAM market leader. The combination creates a dynamic identity security provider offering scalable, world-class products in an environment where cyber-attacks are increasing in frequency and sophistication. The acquisition of Thycotic from Insight Partners and subsequent merger follows TPG’s previously announced acquisition of Centrify, which has now closed.